{"filing":{"accession_number":"0001628280-26-048043","cik":"0001417663","ticker":"SNWV","company_name":"SANUWAVE Health, Inc.","form":"8-K","filing_date":"2026-07-13","report_date":null,"primary_document":"snwv-20260713.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/snwv-20260713.htm"},"events":[{"id":17634,"run_id":15802,"accession_number":"0001628280-26-048043","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Sanuwave issued a press release on July 13, 2026 announcing preliminary Q2 2026 financial results (revenues of $9.6–$9.8 million), which exceeded revised guidance. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, the standard format for earnings releases. The results are material to investors assessing the company's operational performance and revenue trajectory.","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-07-13","form":"8-K","submitted_at":null,"items":[{"id":16184,"accession_number":"0001628280-26-048043","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Sanuwave issued a press release on July 13, 2026 announcing preliminary Q2 2026 financial results (revenues of $9.6–$9.8 million), which exceeded revised guidance. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, the standard format for earnings releases. The results are material to investors assessing the company's operational performance and revenue trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:39:48.975304+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16184,"accession_number":"0001628280-26-048043","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Sanuwave issued a press release on July 13, 2026 announcing preliminary Q2 2026 financial results (revenues of $9.6–$9.8 million), which exceeded revised guidance. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, the standard format for earnings releases. The results are material to investors assessing the company's operational performance and revenue trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:39:48.975304+00:00","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-07-13"}]}